Russell Exchange Traded Funds Trust ONEF 深 滬
等待開盤 06-25 09:30:00 美东时间
0.00
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 總市值 0
- 52周最高 0.00
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 --
- 歷史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 0.00
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kingstone taps Sylvie Widjaja to lead California business as vice president
Kingstone taps Sylvie Widjaja to lead California business as vice president Kingstone appointed Sylvie Widjaja as vice president, California business leader at KINS Insurance Agency. Widjaja will lead the California rollout as Kingstone enters the state’s homeowners market on an excess and surplus l
06-22 20:30
Nova Minerals completes U.S. redomicile, shares and warrants trade on NYSE American under NVA, NVAWS
Nova Minerals completes U.S. redomicile, shares and warrants trade on NYSE American under NVA, NVAWS Nova Minerals completed its redomicile to the US, shifting its primary listing to NYSE American. Common stock now trades on NYSE American as NVA; listed warrants trade as NVAWS. Secondary trading con
06-22 18:30
America's Car-Mart amends credit agreement with Silver Point-led lenders for covenant relief
America's Car-Mart amends credit agreement with Silver Point-led lenders for covenant relief America’s Car-Mart amended its Credit and Guaranty Agreement with Silver Point Finance as administrative agent to preserve liquidity during a strategic review. Deal waives specified defaults, grants covenant
06-20 09:00
Lite Strategy joins panel at Litecoin Foundation Summit
Lite Strategy joins panel at Litecoin Foundation Summit Lite Strategy will appear on a featured panel at the Litecoin Foundation Summit in Amsterdam on June 22-23, 2026. The panel, “Litecoin’s institutional opportunity,” is scheduled for June 22, 2026 at 14:00 CEST at the Tobacco Theatre. Disclaimer
06-19 20:30
West Bancorporation updates financial calendar with quarterly results release, conference call
West Bancorporation updates financial calendar with quarterly results release, conference call West Bancorporation will release Q2 2026 results on July 23, 2026, before the U.S. market open. Management will host an earnings conference call at 2:00 p.m. Central on July 23, 2026. Disclaimer: This news
06-19 20:30
USA Rare Earth CFO presents at J.P. Morgan Natural Resources Conference
USA Rare Earth CFO presents at J.P. Morgan Natural Resources Conference USA Rare Earth will present at the J.P. Morgan Natural Resources Conference on June 23, 2026. Chief Financial Officer William Robert Steele Jr. is scheduled to speak at 10:55 a.m. ET. Disclaimer: This news brief was created by P
06-19 19:00
Ensign Group declares quarterly dividend of $0.065 per share
Ensign Group declares quarterly dividend of $0.065 per share Ensign declared a quarterly cash dividend of USD 0.065 per common share. Payable on or before July 31, 2026, to shareholders of record as of June 30, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generat
06-19 18:00
Nasdaq corrects QMMM delisting notice after replacing SEC trading suspension link
Nasdaq corrects QMMM delisting notice after replacing SEC trading suspension link Nasdaq issued a correction to its June 17 release on QMMM Holdings’ anticipated delisting, replacing the SEC trading-suspension link. The notice still sets a June 24 delisting date unless QMMM appeals to a Nasdaq heari
06-18 22:43
Standard Premium Finance holds annual shareholder meeting; investors back executive pay vote frequency
Standard Premium Finance holds annual shareholder meeting; investors back executive pay vote frequency Standard Premium Finance Holdings held its annual shareholders meeting on June 12, 2026. Shareholders endorsed an advisory resolution on executive compensation. Shareholders backed a triennial sche
06-18 22:05
GRI Bio wins FDA orphan drug designation for GRI-0621 in pulmonary fibrosis
GRI Bio wins FDA orphan drug designation for GRI-0621 in pulmonary fibrosis FDA granted orphan drug designation to GRI-0621 (tazarotene) for idiopathic pulmonary fibrosis. Designation could support 7 years of US market exclusivity if the drug wins approval. GRI-0621 is a once-daily oral RARβ/γ-selec
06-18 20:31
